Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Luciana Raya-Plasencia :Writing review & editing, Investigation, Formal analysis, Conceptualization
The agency's Adverse Event Reporting System (FAERS) database contained three adverse events tied to compounded injectable BPC-157, including a case in which a patient developed diffuse hyperpigmentation and gingival darkening after using a blended BPC-157/TB-500 product labeled "research purposes only." The most clinically specific safety concern for BPC-157 is its mechanism of action
For example, in the case of mucus production, systemic drugs can lead to dysfunction of other organs (e.g., digestion problems because of reduced mucus production in the gastrointestinal tract)
Ongoing research is currently investigating the regenerative capabilities of TB-500 in diverse fields
US$ 23.25
US$ 24.37
US$ 28.99
